FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Molina Healthcare: Q1 Eps Beats, Guidance Maintained

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

Molina Healthcare reported mixed Q1 results, with adjusted EPS of $2.35 declining 61% Y/Y but beating the $1.94 consensus estimate. Revenue of $10.8B missed consensus by ~0.8%, with premium revenues down 4% due to membership losses that reduced total membership to 5.0M from 5.8M. We believe the largest membership losses in Marketplace reflect MOH's pricing and strategic portfolio adjustments, as well as industry pressure from ACA enhanced premium tax credit expiration. MOH reaffirmed full-year 2026 guidance of approximately $42B in premium revenue and at least $5.00 in adjusted EPS. Elevated medical costs continue pressuring results, with consolidated MCR deteriorating to 91.1% from 89.2% in the prior year, though Medicaid's 92.0% ratio was viewed favorably by management relative to expectations. We anticipate more comprehensive forward guidance during the Investor Day on May 8 and Q2 results in July. We expect MOH will face headwinds from Medicaid membership reductions under the One Big Beautiful Bill Act.

Related Articles

Commodities

US Natural Gas Stocks Rise by 103 Bln Cubic Feet in Week Ended April 17 Vs. Expected 96 Bln Increase; Prior Gain of 59 Bln

Research

Research Alert: Pool: Q1 Beat On Maintenance Strength; Maintains Full-year Guidance

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:POOL posted Q1 2026 adjusted EPS of $1.43, up 8.4%, beating the $1.37 consensus estimate. Revenue of $1,138.0M, up 6.2%, beat the $1,098M estimate due to momentum in maintenance products and gradual improvement in discretionary purchases. We believe guidance is achievable given easier year-over-year comparisons and stabilization signs in discretionary spending. POOL maintained full-year EPS guidance of $10.87-$11.17, with the midpoint in line with consensus and implying 3% EPS growth, the first growth since 2022. Gross margins declined 20bps to 29.0% due to seasonal mix headwinds, though operating leverage from slower SG&A growth maintained stable 7.3% operating margins. Inventory levels rose 14% to $1.7B, reflecting higher purchase levels, an important metric to monitor as elevated levels could signal either anticipated demand improvement or potential margin pressure. We view continued macroeconomic volatility and housing market weakness as key risks that could pressure discretionary purchases.

$POOL
Australia

Barclays Adjusts Price Target on CME Group to $316 From $343, Maintains Equalweight Rating

CME Group (CME) has an average rating of hold and mean price target of $312.73, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $283.45, Change: $-2.26, Percent Change: -0.79%

$CME